Table 1.
Antibiotic | All isolates n=345 |
West n=108 |
Central n=86 |
East n=151 |
P-value |
---|---|---|---|---|---|
Amoxicillin | 6.4% (22) | 8.3% (9) | 5.8% (5) | 5.3% (8) | 0.6 |
Clarithromycin | 17.4% (60) | 11.1% (12) | 15.1% (13) | 23.2% (35) | 0.03 |
Metronidazole | 43.6% (150)* | 35.5% (38)* | 43.0% (37) | 49.7% (75) | 0.08 |
Rifabutin | 0.0% (0) | 0.0% (0) | 0.0% (0) | 0.0% (0) | ND |
Limited Analysis n=71 |
n=19 | n=19 | n=33 | ||
Tetracycline | 2.8% (2) | 5.3% (1) | 5.3% (1) | 0 (0.0%) | 0.3 |
Levofloxacin | 57.8% (41) | 57.8% (11) | 68.4% (13) | 17 (51.5%) | 0.5 |
Metronidazole susceptibilities were available for 107 isolates from the West region and 344 isolates in total.